Inmotion Interactive therapy
InMotion Robots have been tested by leading medical centers in dozens of controlled clinical trials, including large randomized controlled clinical studies. Through our research, we have discovered that the best way to optimize robot therapy is by allowing the robots to focus on reducing impairments and allowing the therapist to assist on translating the gains in impairment into function.
Bionik’s modular systems approach to neurorehabilitation is the only system designed to optimize the use of robotics in a manner that is consistent with the latest clinical research and neuroscience, taking into account the latest understanding on motor learning interference and motor memory consolidation.
Clinical Results
In a multi-center, randomized controlled trial involving 127 chronic stroke patients with moderate to severe upper-limb impairment, our assist-as-needed™ therapy demonstrated significant improvement in arm movement, function and quality of life. The study also found that “the improvements provide evidence of potential long-term benefits of rehabilitation and challenge the widely held clinical belief that gains in motor function are not possible for long term stroke survivors.”1
In a controlled clinical study involving 56 stroke inpatients, the motor skills of the robot-treated group improved significantly more than the control group. Analysis showed that interactive robotic therapy significantly reduced motor impairment of the treated limbs, doubling the impairment reduction.2
A multi-center VA study of 127 patients with long-term severe to moderate upper-limb impairment from a stroke that occurred at least 6 months before enrollment (average time of 4.7 years, 33% with multiple strokes) found that “the improvements provide evidence of potential long-term benefits of rehabilitation and challenge the widely held clinical belief that gains in motor function are not possible for long term stroke survivors.”
